Facial Injectables Market

Facial Injectables Market (Botulinum Toxin, Hyaluronic Acid, Collagen and Polymers and Particles (PPFs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • Rep Id : TMRGL1779
  • Published On : Jul 2014
  • No. of Pages : 72
  • Category : Healthcare

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Facial Injectables Market (2013 and 2020)
2.2 Comparative Analysis: Global Facial Injectbales Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Market Overview
3.1 Overview – Current Market Scenario and Future Market Trends
       3.1.1 Global Facial Injectables Market, by Products, 2012 – 2020 (USD Million)
3.2 Market Drivers
       3.2.1 Increased longevity of the effects is augmenting the demand for facial injectable
       3.2.2 Rising geriatric population is augmenting the demand for facial injectables
       3.2.3 Increasing preference for minimally procedures fueling the growth of facial injectable market
3.3 Market Restraints
       3.3.1 Side effects of available products are limiting the adoption
3.4 Opportunities
       3.4.1 Product innovation and process development to overcome disadvantages of commercially available products
3.5 Porter’s Five Force Analysis for the Global Facial Injectable Market
       3.5.1 Bargaining power of suppliers
       3.5.2 Bargaining power of buyers
       3.5.3 Threat of new entrants
       3.5.4 Threat of substitutes
       3.5.5 Competitive Rivalry
       3.5.6 Market Activeness Analysis of Global Facial Injectable Market, by Geography, 2013
3.6 Value Chain Analysis: Global Facial Injectables Market
3.7 Average Selling Price Analysis: Global Facial Injectable Market
3.8 Market Share Analysis: Global Facial Injectables Market, by Key Players, 2013 (Value %)
 
Chapter 4 Global Facial Injectables Market, by Product Type
4.1 Overview – Current Market Scenario and Future Market Trends
       4.1.1 Global Facial Injectables Market, by Products, 2012 – 2020 (USD Million)
       4.1.2 Comparative Analysis: Global Facial Injectables Market, By Product, 2013 & 2020 (Value %)
4.2 Botulinum Toxin
       4.2.1 Global Botulinum Toxin Market Revenue, 2012 – 2020, (USD Million)
4.3 Hyaluronic Acid
       4.3.1 Global Hyaluronic Acid Market Revenue, 2012 – 2020, (USD Million)
4.4 Collagen
       4.4.1 Global Collagen Market Revenue, 2012 – 2020, (USD Million)
4.5 Particles and Polymers Fillers (PPF)
       4.5.1 Global Particles and Polymer Fillers Market Revenue, by Types, 2012 – 2020, (USD Million)
       4.5.2 Polymethylmethacrylate beads (PMMA microspheres)
               4.5.2.1 Global Polymethylmethacrylate beads (PMMA microspheres)Market Revenue, 2012 – 2020, (USD Million)
       4.5.3 Poly-L-lactic acid
                4.5.3.1 Global Poly-L-lactic acid Market Revenue, 2012 – 2020, (USD Million)
       4.5.4 Calcium hydroxyapatite
               4.5.4.1 Global Calcium Hydroxyapatite Market Revenue, 2012 – 2020, (USD Million)
 
Chapter 5 Global Facial Injectables Market, by Geography
5.1 Overview – Current Market Scenario and Future Market Trends
       5.1.1 Global Facial Injectables Market, by Geography, 2012 – 2020 (USD Million)
5.2 North America
       5.2.1 North America Facial Injectables Market, By Product Type, 2012 - 2020 (USD Million)
5.3 Europe
       5.3.1 Europe Facial Injectables Market, by Product Type 2012 – 2020 (USD Million)
5.4 Asia-Pacific
       5.4.1 Asia Pacific Facial Injectables Market, by Product Type 2012 – 2020 (USD Million)
5.5 Rest of the World (RoW)
       5.5.1 RoW Facial Injectables Market, by Product Type 2012 – 2020 (USD Million)
 
Chapter 6 Recommendations
6.1 Research and development initiatives
6.2 International players should establish partnership with local professional/organization to expand their business
 
Chapter 7 Company Profiles
7.1.1 Company Overview
       7.1.2 Financial Overview
       7.1.3 Product Portfolio
       7.1.4 Business Strategies
       7.1.5 Recent Developments
7.2 Bloomage BioTechnology Corporation Limited
       7.2.1 Company Overview
       7.2.2 Financial Overview
       7.2.3 Product Portfolio
7.3 Galderma S.A.
       7.3.1 Company Overview
       7.3.2 Financial Overview
       7.3.3 Product Portfolio
       7.3.4 Business Strategies
       7.3.5 Recent Developments
7.4 Ipsen Group
       7.4.1 Company Overview
       7.4.2 Financial Overview
       7.4.3 Product Portfolio
       7.4.4 Business Strategies
       7.4.5 Recent Developments
7.5 Merz Pharma GmbH & Co. KGaA
       7.5.1 Company Overview
       7.5.2 Financial Overview
       7.5.3 Product Portfolio
       7.5.4 Business Strategies
       7.5.5 Recent Developments

List of Tables
 
TABLE 1 Market Snapshot: Global Facial Injectables Market (2013 and 2020)
TABLE 2 Global Facial Injectables Market Revenue, by Products, 2012 – 2020 (USD Million)
TABLE 3 Global Facial Injectbales Market Revenue, by Products, 2012 – 2020 (USD Million)
TABLE 4 Global Facial Injectables Market Revenues, by Geography, Size and Forecast, 2012 - 2020 (USD Million)
TABLE 5 North America Facial Injectables Market, by Product Type, 2012 - 2020 (USD Million)
TABLE 6 Europe Facial Injectables Market, by Product Type, 2012 - 2020 (USD Million)
TABLE 7 Asia Pacific Facial Injectables Market, by Product Type, 2012 - 2020 (USD Million)
TABLE 8 RoW Facial Injectables Market, by Product Type, 2012 - 2020 (USD Million)

List of Figures
 
FIG. 1 Market Segmentation: Global Facial Injectables Market
FIG. 2 Global Facial Injectables Market Revenue, by Product, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global Facial Injectables Market, by Geography, 2013 & 2020 (Value %)
FIG. 4 Porter’s Five Force Analysis: Global Facial Injectables Market
FIG. 5 Market Attractiveness Analysis: Global Facial Injectables Market, by Geography
FIG. 6 Value Chain Analysis: Global Facial Injectables Market
FIG. 7 Market Share Analysis: Global Facial Injectables Market, by Key Players, 2013 (Value %)
FIG. 8 Comparative Analysis: Global Facial Injectables Market, by Products, 2013 & 2020 (Value %)
FIG. 9 Global Botulinum Toxin Market Revenue, 2012 – 2020, (USD Million)
FIG. 10 Global Hyaluronic Acid Market Revenue, 2012 – 2020, (USD Million)
FIG. 11 Global Collagen Market Revenue, 2012 – 2020, (USD Million)
FIG. 12 Global Particles and Polymer Fillers  Market Revenue, 2012 – 2020, (USD Million)
FIG. 13 Global Polymethylmethacrylate beads (PMMA microspheres)Market Revenue, 2012 – 2020, (USD Million)
FIG. 14 Global Poly-L-lactic acid Market  Revenue, 2012 – 2020, (USD Million)
FIG. 15 Global Calcium Hydroxyapatite Market Revenue, 2012 – 2020, (USD Million)
FIG. 16 Allergan, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 17 Bloomage BioTechnology Corporation Limited: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 18 Galderma S.A.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 19 Ipsen Group: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 20 Merz GmbH & Co. KGaA: Annual Revenue, 2011 – 2013 (USD Million)